1. World Health Organization (WHO). Additional Guidance for Organizations Performed in vivo Bioequivalence Studies. Working document QAS/05.120/Rev.1. Draft Revision. November 2005
2. Jones AB (2003) Principles in quality assurance. Part 2: don’t hide behind the regulations. Qual Assur J 7(1):4–10
3. US Department of Health and Human Services. Food and Drug Administration(US-FDA), Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM). Guidance for Industry Bioanalytical Method Validation, May 2001
4. Midha KK, Rawson MJ, Hubbard JW (2004) Commentary: the role of metabolites in bioequivalence. Pharm Res 21:1331–1344
5. US Department Of Health and Human Services Food and Drug Administration (US-FDA). Centre for Drug Evaluation and Research (cder). Guidance for Industry: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products-General Considerations, October 2000